# PeRfusiOn Post tHrombEcTomy (PROPHET)

> **NCT06691230** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 279 (estimated)

## Conditions studied

- Stroke, Acute, Ischemic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06691230
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-02-28
- **Target enrollment:** 279 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06691230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06691230, "PeRfusiOn Post tHrombEcTomy (PROPHET)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06691230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*